David Malcom Rodman, Chief Medical Officer at Mineralys Therapeutics, Inc. (MLYS), sold 14,474 shares at $23.81 ($350K) on 2026-06-15, disclosed to the SEC on 2026-06-17.
Scheduled sale ($350k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.81 | 9,890 | $235K | 67.3% |
| 2 | $25.00 | 4,584 | $115K | 32.7% |
| Total | $24.19 avg | 14,474 | $350K | 100% |
| Filing → |
| MLYS | SELL | 2026-07-15 | $557K | — | Filing → |
| MLYS | SELL | 2026-07-10 | $66K | — | Filing → |
| MLYS | SELL | 2026-06-12 | $206K | — | Filing → |